Plasma carboxypeptidase B downregulates inflammatory responses in autoimmune arthritis
Authors:
- Inyong HwangIHInyong Hwang
- Kyung H. ChoKCKyung H. Cho
- Michael A. GarciaMGMichael A. Garcia
- Arthur J. KimAKArthur J. Kim
- Tiffany H. WangTWTiffany H. Wang
- Tamsin M. LindstromTLTamsin M. Lindstrom
- Annette T. LeeALAnnette T. Lee
- Toshihiko NishimuraTNToshihiko Nishimura
- Lei ZhaoLZLei Zhao
- John MorserJMJohn Morser
- Michael NesheimMNMichael Nesheim
- 1 August 2011
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 121 (9) , 3517-3527
Abstract
The immune and coagulation systems are both implicated in the pathogenesis of rheumatoid arthritis (RA). Plasma carboxypeptidase B (CPB), which is activated by the thrombin/thrombomodulin complex, plays a procoagulant role during fibrin clot formation. However, an antiinflammatory role for CPB is suggested by the recent observation that CPB can cleave proinflammatory mediators, such as C5a, bradykinin, and osteopontin. Here, we show that CPB plays a central role in downregulating C5a-mediated inflammatory responses in autoimmune arthritis. CPB deficiency exacerbated inflammatory arthritis in a mouse model of RA, and cleavage of C5a by CPB suppressed the ability of C5a to recruit immune cells in vivo. In human patients with RA, genotyping of nonsynonymous SNPs in the CPB-encoding gene revealed that the allele encoding a CPB variant with longer half-life was associated with a lower risk of developing radiographically severe RA. Functionally, this CPB variant was more effective at abrogating the proinflammatory properties of C5a. Additionally, expression of both CPB and C5a in synovial fluid was higher in patients with RA than in those with osteoarthritis. These findings suggest that CPB plays a critical role in dampening local, C5a-mediated inflammation and represents a molecular link between inflammation and coagulation in autoimmune arthritis.Keywords
This publication has 61 references indexed in Scilit:
- Efficient osteoclast differentiation requires local complement activationBlood, 2010
- Radiographic severity of Rheumatoid Arthritis in African Americans: Results from a multicenter observational studyArthritis Care & Research, 2010
- Activated protein C action in inflammationBritish Journal of Haematology, 2010
- c-Fms-mediated differentiation and priming of monocyte lineage cells play a central role in autoimmune arthritisArthritis Research & Therapy, 2010
- Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin αMβ2 binding motifJournal of Clinical Investigation, 2007
- Thrombin-activatable procarboxypeptidase B regulates activated complement C5a in vivoBlood, 2006
- Selective tyrosine kinase inhibition by imatinib mesylate for the treatment of autoimmune arthritisJournal of Clinical Investigation, 2006
- Essential role of neutrophils in anti‐type II collagen antibody and lipopolysaccharide‐induced arthritisImmunology, 2006
- The interactions between inflammation and coagulationBritish Journal of Haematology, 2005
- Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritisArthritis & Rheumatism, 1991